Drug induced movement disorder, unspecified
ICD-10 G25.70 is a billable code used to indicate a diagnosis of drug induced movement disorder, unspecified.
Drug induced movement disorder, unspecified (G25.70) refers to a range of involuntary movements that are caused by the administration of certain medications, particularly those affecting the dopaminergic system. These disorders can manifest as tremors, rigidity, bradykinesia, and other abnormal movements that resemble Parkinson's disease or extrapyramidal symptoms. The condition is often associated with the use of antipsychotic medications, particularly first-generation antipsychotics, which can lead to extrapyramidal side effects. Symptoms may develop shortly after the initiation of medication or after dosage adjustments. The diagnosis is made based on clinical evaluation, including a thorough medication history and assessment of movement abnormalities. It is crucial to differentiate drug-induced movement disorders from primary movement disorders such as Parkinson's disease, as the management and treatment strategies differ significantly. Treatment typically involves adjusting the offending medication, using anticholinergic agents, or switching to atypical antipsychotics with a lower risk of extrapyramidal symptoms. Accurate coding is essential for appropriate treatment and reimbursement.
Detailed neurological examination findings, medication history, and symptom onset timeline.
Patients presenting with new-onset tremors after starting antipsychotic therapy.
Consideration of alternative diagnoses and the need for follow-up assessments.
Comprehensive psychiatric evaluation, including medication management history and side effect monitoring.
Patients experiencing movement disorders while on psychotropic medications.
Documentation of the rationale for medication choices and adjustments.
Used for follow-up visits to assess movement disorder symptoms.
Documentation of history, examination, and medical decision-making.
Neurologists and psychiatrists should ensure comprehensive notes on medication adjustments.
G25.70 is used for unspecified drug-induced movement disorders, while G25.71 is specifically for drug-induced parkinsonism, requiring documentation of parkinsonian symptoms.
